Log in

Vertex Pharmaceuticals Price Target & Analyst Ratings (NASDAQ:VRTX)

+2.78 (+1.26 %)
(As of 12/6/2019 08:07 AM ET)
Today's Range
Now: $223.91
50-Day Range
MA: $203.83
52-Week Range
Now: $223.91
Volume937,011 shs
Average Volume1.29 million shs
Market Capitalization$57.58 billion
P/E Ratio79.12
Dividend YieldN/A

Analyst Ratings

Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
25 Wall Street analysts have issued ratings and price targets for Vertex Pharmaceuticals in the last 12 months. Their average twelve-month price target is $219.07, suggesting that the stock has a possible downside of 2.16%. The high price target for VRTX is $254.00 and the low price target for VRTX is $165.71. There are currently 6 hold ratings and 19 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.762.712.672.67
Ratings Breakdown: 0 Sell Rating(s)
6 Hold Rating(s)
19 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
17 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
7 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
8 Hold Rating(s)
16 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $219.07$215.98$211.78$205.00
Price Target Upside: 2.16% downside8.72% upside16.63% upside23.36% upside

Vertex Pharmaceuticals (NASDAQ:VRTX) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Vertex Pharmaceuticals (NASDAQ:VRTX) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/20/2019BMO Capital MarketsBoost Price TargetOutperform ➝ Positive$248.00Low
11/19/2019CowenReiterated RatingBuyLow
11/19/2019GuggenheimUpgradeNeutral ➝ Buy$252.00High
11/12/2019SunTrust BanksInitiated CoverageBuy$235.00Medium
11/4/2019Credit Suisse GroupReiterated RatingBuy$228.00Low
11/1/2019Maxim GroupReiterated RatingHoldHigh
10/31/2019Piper Jaffray CompaniesBoost Price TargetOverweight$230.00 ➝ $247.00High
10/22/2019Leerink SwannBoost Price TargetMarket Perform$186.00 ➝ $203.00High
10/22/2019CitigroupBoost Price TargetBuy$205.00 ➝ $225.00High
10/21/2019Jefferies Financial GroupSet Price TargetBuy$220.00Medium
10/21/2019Robert W. BairdSet Price TargetBuy$210.00Medium
10/21/2019JPMorgan Chase & Co.Set Price TargetBuy$218.00Medium
10/16/2019Bank of AmericaInitiated CoverageBuy$220.00Medium
9/6/2019Morgan StanleyBoost Price TargetOverweight$215.00 ➝ $240.00Low
9/3/2019Goldman Sachs GroupUpgradeNeutral ➝ Buy$226.00 ➝ $254.00High
8/12/2019Royal Bank of CanadaSet Price TargetBuy$213.00Low
8/1/2019Stifel NicolausBoost Price TargetBuy$205.00 ➝ $211.00Low
8/1/2019HC WainwrightReiterated RatingBuy$220.00High
8/1/2019Needham & Company LLCDowngradeBuy ➝ HoldHigh
4/11/2019Evercore ISIInitiated CoverageIn-Line$183.00Low
3/26/2019William BlairUpgradeMarket Perform ➝ Outperform$183.85Medium
3/19/2019Svb LeerinkReiterated RatingOutperform ➝ Market PerformHigh
3/7/2019OppenheimerBoost Price TargetOutperform ➝ Outperform$200.00 ➝ $230.00Low
1/2/2019Raymond JamesDowngradeOutperform ➝ Market Perform$165.71Low
12/17/2018Cantor FitzgeraldReiterated RatingBuy$217.00High
8/28/2018ArgusBoost Price TargetBuy ➝ Average$200.00High
7/26/2018UBS GroupBoost Price TargetNeutral ➝ Neutral$183.00 ➝ $188.00High
2/13/2018JMP SecuritiesReiterated RatingMarket Outperform ➝ Outperform$200.00 ➝ $211.00Low
2/1/2018BarclaysBoost Price TargetOverweight ➝ Overweight$180.00 ➝ $200.00High
12/12/2017Deutsche BankInitiated CoverageBuy$175.00High
(Data available from 12/6/2017 forward)
This page was last updated on 12/6/2019 by MarketBeat.com Staff

Featured Article: Equal Weight Rating

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel